NCT Number: NCT00142701
Enhancing Support for Women at Risk for Heart Disease
To test a practical, theory-based intervention to achieve long-term behavior change for postmenopausal women with Type 2 diabetes at high risk for developing coronary heart disease (CHD).
Looking for future studies?
Notify MeKey information
Conditions
Age range
Up to 100 year
Sex eligibility
Female
Study type
Interventional
Phase
Not applicable
About this study
BACKGROUND:
The overall goal of this study was to test a practical, theory-based intervention to achieve long-term behavior change for women with Type 2 diabetes at high risk for developing coronary heart disease (CHD). Epidemiological and clinical studies suggest that diabetes is associated with increased risk for CHD that is greater in women than in men. CHD is a major cause of death and functional limitations in women, but the vast majority of CHD studies have primarily involved middle-aged men. There is convincing research evidence that healthy lifestyle behaviors, including low-fat diet, physical activity, stress management, smoking cessation, and social support, can reduce CHD risk
The study was initiated in response to a Request for Applications released in October 1997 by the National Institutes of Health Office of the Director on "Innovative Approaches to Disease Prevention Through Behavior Change."
DESIGN NARRATIVE:
The study was a randomized trial to compare short-term (6-month) outcomes in women receiving usual care compared to a modified Ornish-type comprehensive lifestyle management (CLM) intervention. Participants (N = 279) were randomized to usual care (UC) or Mediterranean Lifestyle Program, a lifestyle change intervention aimed at the behavioral risk factors (eating patterns, physical activity, stress management, and social support) affecting risk for CHD in postmenopausal women with type 2 diabetes. After 6 months, women in the CLM condition were randomized to one of two approaches for providing support either lay-led group support or personalized computer-based support - to evaluate these strategies in enhancing longer-term maintenance of effects. Outcomes included multiple CHD lifestyle behaviors (e.g., dietary intake, exercise levels, stress management, smoking cessation), physiological risk factors associated with CHD (e.g., serum lipids, hypertension, weight, vascular reactivity), HbA1c (glycated hemoglobin, a measure of diabetes), and quality of life (e.g., depression, functioning).
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
No eligibility criteria
Treatment and study plan
Physical activity
BehavioralStress Management
Behavioralsmoking cessation
BehavioralSponsors and collaborators
Lead sponsor
Oregon Research Institute
Other
Collaborators
- National Heart, Lung, and Blood Institute (NHLBI)
Registry information
Important dates
- Study start
- 1999
- Primary completion
- 2004
- Study completion
- 2005
- First posted
- Sep 2, 2005
- Registry last updated
- Feb 8, 2016
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Mechanisms of Pro-Thrombosis in Diabetes Mellitus -- Ancillary to BARI 2D
NCT00041405
Cardiovascular Diseases, Coronary Disease
View Trial DetailsVA HDL Intervention Trial (VA-HIT) Ancillary Study Data Analysis
NCT00035711
Body Weight, Brain Diseases
View Trial DetailsIncidence of Diabetes and Cardiovascular Disease in Mexican Americans
NCT00005205
Angina Pectoris, Brain Diseases
View Trial DetailsGenetics of the Metabolic Syndrome in Japanese Americans
NCT00005374
Cardiovascular Diseases, Coronary Disease
View Trial Details